Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Tranexamic acid for post-partum haemorrhage in the WOMAN trial

As one of the many collaborators who contributed to the WOMAN trial1 our team’s involvement in research that will improve maternal outcomes globally has been gratifying. 1 g of intravenous tranexamic acid given within 3 h of post-partum haemorrhage significantly reduced maternal death and the need for surgery (laparotomy). The fact that post-partum haemorrhage was defined as 500 mL or more for vaginal deliveries but 1000 mL or more for caesarean section is important to note. This difference should be considered when clinicians update local guidelines for post-partum haemorrhage.